Statins in primary prevention: is the enthusiasm justified?

Statins in primary prevention: is the enthusiasm justified?

Bibliographic Details
Main Authors:	Arun K. Chopra, Rakesh Yadav
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	Indian Heart Journal
Subjects:	Primary prevention Statins
Online Access:	http://www.sciencedirect.com/science/article/pii/S001948322030184X

Similar Items

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
by: Marina G. Bubnova, et al.
Published: (2021-06-01)

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Interpretation of the U.S. Preventive Services Task Force Recommendation Statement
by: SHI Weili, LI Mingyan, DUAN Hongyan
Published: (2024-04-01)

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)
by: Michael D. Miedema, et al.
Published: (2018-06-01)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
by: Frances M. Wang, et al.
Published: (2023-03-01)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
by: Michael M. Hammond, et al.
Published: (2023-04-01)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
by: Jeffrey D. Clough, et al.
Published: (2019-02-01)

Cost-effectiveness analysis of statins in primary care: results from the Arteris cohort study
by: Michel Romanens, et al.
Published: (2021-04-01)

The correlation of the efficacy and safety of statins with the aim of primary and secondary prevention: myths and reality
by: S R Gilyarevsky, et al.
Published: (2015-06-01)

Multimorbidity and statin prescription for primary prevention of cardiovascular diseases: A cross-sectional study in general practice in France
by: Racha Onaisi, et al.
Published: (2023-01-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study, Northeast Ethiopia
by: Melaku EE, et al.
Published: (2023-11-01)

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
by: Michael G. Nanna, et al.
Published: (2018-05-01)

Statin use in older people primary prevention on cardiovascular disease: an updated systematic review and meta-analysis
by: Hao Huang, et al.
Published: (2022-03-01)

Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
by: Gebre Teklemariam Demoz, et al.
Published: (2019-07-01)

Statin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United States
by: Mitchell Aaron P, et al.
Published: (2012-07-01)

Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance
by: S. R. Gilyarevskiy, et al.
Published: (2013-12-01)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
by: Hassan Saadati, et al.
Published: (2020-11-01)

Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care
by: Alvaro Sanchez, et al.
Published: (2022-10-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
by: Kamal Awad, et al.
Published: (2021-06-01)

Statins in Healthy Adults: A Meta-Analysis
by: Lee Sandwith, et al.
Published: (2021-06-01)

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
by: Thongtang N, et al.
Published: (2020-02-01)

The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?
by: Vasiliki Katsi, et al.
Published: (2017-05-01)

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
by: Henock G. Yebyo, et al.
Published: (2018-05-01)

Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States
by: Emily Decicco, et al.
Published: (2023-12-01)

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
by: Henock G. Yebyo, et al.
Published: (2020-09-01)

STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY
by: Y. A. Karpov
Published: (2015-12-01)

Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data
by: O’Keeffe AG, et al.
Published: (2016-05-01)

Crosstalk between Statins and Cancer Prevention and Therapy: An Update
by: Beniamin Oskar Grabarek, et al.
Published: (2021-11-01)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
by: Miao Wang, et al.
Published: (2020-06-01)

New clinical and pharmacological aspects of the use of atorvastatin for primary and secondary prevention of complications of cardiovascular diseases
by: S. R. Gilyarevsky, et al.
Published: (2018-09-01)

An education-behavioural intervention improves adherence to statins
by: Kardas Przemyslaw
Published: (2013-10-01)

Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
by: Kebede zelalem B, et al.
Published: (2020-12-01)

Statins in primary prophylaxis of cardiovascular diseases
by: Zhanna Davidovna Kobalava, et al.
Published: (2011-09-01)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
by: Sydney B Long, et al.
Published: (2010-12-01)

An analysis of the effect of statins on the risk of Non‐Hodgkin's Lymphoma in the Women’s Health Initiative cohort
by: Pinkal Desai, et al.
Published: (2018-05-01)

Statins in Cancer Prevention and Therapy
by: Natalia Ricco, et al.
Published: (2023-08-01)

Coronary Artery Calcium Score–Directed Primary Prevention With Statins on the Basis of the 2018 American College of Cardiology/American Heart Association/Multisociety Cholesterol Guidelines
by: Jana Taron, et al.
Published: (2021-01-01)